Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Compliance
Medtronic Subsidiaries Plead Guilty and Settle Various Allegations
On December 4, 2018, the United States Department of Justice announced settlements with two of Medtronic’s subsidiaries, Covidien…
HHS OIG Issues Unfavorable Opinion Regarding Drug Company’s Plan to Provide…
On November 16, 2018, the Office of the Inspector General of the Department of Health and Human Services (HHS-OIG) released…
AmerisourceBergen Resolves Civil Fraud Charges, Agrees To Pay $625 Million
On Monday, October 1, 2018, the United States Department of Justice (DOJ) announced a $625 million agreement to resolve civil…
Where is the grass greener?
Considering both financial services and life science industries typically make it onto the top 10 list of most regulated…
Aegerion Sentenced to Pay $7.2 Million to Patients
On January 30, 2018, Federal U.S. District Court Judge William Young sentenced Aegerion to pay some of the roughly $36 million…
CMS Changes Policy Regarding Enforcement Actions
On October 27, 2017, CMS issued a draft Survey and Certification Memo (S & C Memo) in which it announced its intention to…
AARP v. EEOC : Motion to Vacate Granted
In AARP vs. EEOC, U.S. District Court Judge John D. Bates granted a motion by AARP to vacate the EEOC’s current wellness…
A Compliance New Year’s Resolution – Assess the Company’s Culture
The topic of ‘company culture’ is certainly not new, but it continually emerges as a hot topic within regulatory circles. An…
HHS OIG Releases Report on Potential Drug Misclassifications
A report recently released by the Department of Health and Human Services (HHS) Office of Inspector General (OIG) found that…
OPDP Letters Remain on Decline
The Office of Prescription Drug Promotion (OPDP) is known for monitoring company communications about medical products and when it…